Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 126,907 $ 155,714
Equity method investments 2,298,962 1,869,712
Receivables 2,231,000  
Receivables held-for-sale 5,244 85,254
Real estate 351,455 353,000
Investments 10,213 10,200
Securitization assets 203,743 177,032
Other assets 147,993 119,242
Total Assets 5,375,229 4,760,148
Liabilities:    
Accounts payable, accrued expenses and other 114,446 120,114
Credit facilities 282,859 50,698
Commercial paper notes 100,044 192
Term loan facility 374,996 379,742
Senior unsecured notes 1,770,047 1,767,647
Convertible notes 348,982 344,253
Total Liabilities 3,381,324 3,095,402
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 106,769,719 and 90,837,008 shares issued and outstanding, respectively 1,068 908
Additional paid in capital 2,283,255 1,924,200
Accumulated deficit (326,413) (285,474)
Accumulated other comprehensive income (loss) (8,003) (10,397)
Non-controlling interest 43,998 35,509
Total Stockholders’ Equity 1,993,905 1,664,746
Total Liabilities and Stockholders’ Equity 5,375,229 4,760,148
Non-recourse debt    
Liabilities:    
Non-recourse debt (secured by assets of $599 million and $632 million, respectively) 389,950 432,756
Commercial receivables    
Assets    
Receivables 2,134,154 1,887,483
Government receivables    
Assets    
Receivables $ 96,558 $ 102,511